FDA Clearance Tracker · K240426
Aventus Clot Management System
Last checked: Nov 20, 2026Latest source record: May 14, 2024 (this decision)Source: openFDAMethods & limitations
Decided
May 14, 2024
Substantially Equivalent
Time to decision
91 days
Received Feb 13, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K240426
- Device name
- Aventus Clot Management System
- Applicant
- Inquis Medical
- Applicant location
- Menlo Park, CA
- Received
- Feb 13, 2024
- Decided
- May 14, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Apparatus, Autotransfusion (CAC)
- Device class
- Class II
- Regulation
- 21 CFR 868.5830
- Specialty
- Anesthesiology & Respiratory
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code CAC. The earliest in FDA's data is K772196, decided Dec 22, 1977.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K240426
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Inquis Medical
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261105 · Decided Jul 27, 2026 · 115 days after receipt
Device type: Aspiration Thrombectomy Catheter (QEZ) · Cardiology
K262030 · Decided Jul 15, 2026 · 28 days after receipt
Device type: Aspiration Thrombectomy Catheter (QEZ) · Cardiology
K260091 · Decided Apr 13, 2026 · 91 days after receipt
Device type: Introducer, Catheter (DYB) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.